Pierre Loulergue

Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial

Andrew J. Pollard, Odile Launay, Jean‐Daniel Lelièvre et al. · The Lancet Infectious Diseases · 2020 · 170 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Knowledge, attitudes and vaccination coverage of healthcare workers regarding occupational vaccinations

Pierre Loulergue, Flore Moulin, G. Vidal-Trécan et al. · Vaccine · 2009 · 169 citations

Medicine, Infectious Diseases, Immunization +15

Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections

A. Hot, C. Maunoury, S. Poirée et al. · Clinical Microbiology and Infection · 2010 · 160 citations · Full text

Medicine, Infectious Diseases, Radiology +15

Literature Review and Case Histories of<i>Histoplasma capsulatum</i>var.<i>duboisii</i>Infections in HIV-infected Patients

Pierre Loulergue, Frédéric Bastides, Véronique Baudouin et al. · Emerging infectious diseases · 2007 · 148 citations · Full text

Veterinary Medicine, Infectious Diseases, Pathology +14

PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study

Sodiomon B. Sirima, Laura Richert, Arnaud Chêne et al. · The Lancet Infectious Diseases · 2020 · 129 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16